Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Donna M. Dimichele"'
Autor:
Ann T. Farrell, Julie Panepinto, Ankit A. Desai, Adetola A. Kassim, Jeffrey Lebensburger, Mark C. Walters, Daniel E. Bauer, Rae M. Blaylark, Donna M. DiMichele, Mark T. Gladwin, Nancy S. Green, Kathryn Hassell, Gregory J. Kato, Elizabeth S. Klings, Donald B. Kohn, Lakshmanan Krishnamurti, Jane Little, Julie Makani, Punam Malik, Patrick T. McGann, Caterina Minniti, Claudia R. Morris, Isaac Odame, Patricia Ann Oneal, Rosanna Setse, Poornima Sharma, Shalini Shenoy
Publikováno v:
Blood Advances, Vol 3, Iss 23, Pp 4002-4020 (2019)
Abstract: To address the global burden of sickle cell disease and the need for novel therapies, the American Society of Hematology partnered with the US Food and Drug Administration to engage the work of 7 panels of clinicians, investigators, and pat
Externí odkaz:
https://doaj.org/article/06caa969e3bd4e5b84bcc4cdd2e86f79
Autor:
Donna M. DiMichele
Publikováno v:
HemaSphere, Vol 2, Iss 5, p e144 (2018)
Abstract. The unprecedented emergence of novel therapeutics for both hemophilia A and B during the last half decade has been accompanied by the promise of even more extraordinary progress in ameliorative and curative strategies for both disorders. Pa
Externí odkaz:
https://doaj.org/article/3d169de2be0d450ea05bb0b48de04308
Autor:
Donna M. DiMichele
Publikováno v:
Blood Advances, Vol 1, Iss 26, Pp 2655- (2017)
Externí odkaz:
https://doaj.org/article/44aea0583ff94b6da84f4cdf5b307940
Autor:
Jan, Astermark, Sharyne M, Donfield, Edward D, Gomperts, John, Schwarz, Erika D, Menius, Anna, Pavlova, Johannes, Oldenburg, Bailey, Kessing, Donna M, DiMichele, Amy D, Shapiro, Cheryl A, Winkler, Erik, Berntorp, Dragan, Micic
Publikováno v:
Blood. 121(8)
Studies of determinants of development of inhibitory Abs to factor VIII in people with hemophilia A indicate a complex process involving multiple factors. The Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort was formed to extend our underst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d875fad4291d008cf564ce5579f5f6fc
https://pubmed.ncbi.nlm.nih.gov/23429985
https://pubmed.ncbi.nlm.nih.gov/23429985
Publikováno v:
Blood. 119(6)
The International Immune Tolerance Study was a multicenter, prospective, randomized comparison of high-dose (HD; 200 IU/kg/d) and low-dose (LD; 50 IU/kg 3 times/week) factor VIII regimens in 115 “good-risk,” severe high-titer inhibitor hemophilia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c7ef786093e8976eba73ff9b644f3bb
https://pubmed.ncbi.nlm.nih.gov/22323405
https://pubmed.ncbi.nlm.nih.gov/22323405
Knowledge and therapeutic gaps: a public health problem in the rare coagulation disorders population
Publikováno v:
American journal of preventive medicine. 41(6 Suppl 4)
Rare coagulation disorders (RCDs) present a considerable and multifaceted public health risk. Although inherited RCDs affect a minor segment of any local healthcare delivery system, their global impact is major and highlight the challenges of deliver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::34f04cb1be6e8a22f825ff6f8b2ebc5f
https://pubmed.ncbi.nlm.nih.gov/22099354
https://pubmed.ncbi.nlm.nih.gov/22099354
Autor:
Heather, Magnan, Mark L, Kayton, Donna M, DiMichele, David J, Araten, Nancy A, Kernan, Farid, Boulad
Publikováno v:
Pediatric bloodcancer. 53(3)
We describe a patient with paroxysmal nocturnal hemoglobinuria (PNH) and no previous history of thrombosis who presented with hepatic venous thromboses and subsequently developed splenic infarction and rupture requiring splenectomy while on anticoagu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0dc00fe7a6be5a92d6441735b75f489a
https://pubmed.ncbi.nlm.nih.gov/19415735
https://pubmed.ncbi.nlm.nih.gov/19415735
Autor:
W E Hathaway, Donna M. Dimichele
Publikováno v:
American Journal of Hematology. 33:39-45
Twenty-one patients with prolonged bleeding times secondary to inherited disorders of platelet function and eight patients with prolonged bleeding times secondary to acquired platelet dysfunction were given 0.3 micrograms per kilogram of DDAVP, 1-dea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f12698d39ab05d299f009a4d596651c4
https://doi.org/10.1002/ajh.2830330108
https://doi.org/10.1002/ajh.2830330108
The upward spiral of drug costs: a time series analysis of drugs used in the treatment of hemophilia
Autor:
Edward G, Rogoff, Hany S, Guirguis, Richard A, Lipton, Stephanie V, Seremetis, Donna M, DiMichele, George M, Agnew, Margaret, Karpatkin, Robert J, Barish, Robert L, Jones, Celso, Bianco, Barbara D, Knothe, Myung-Soo, Lee
Publikováno v:
Thrombosis and haemostasis. 88(4)
Hemophilia is an expensive disease because its treatment is heavily dependent on costly clotting factor drugs. Over the last nine years,a consortium of three Comprehensive Hemophilia Treatment Centers and other hospitals, which purchased clotting fac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a75b5fd6ed9bfa0192ee670164524a8c
https://pubmed.ncbi.nlm.nih.gov/12362222
https://pubmed.ncbi.nlm.nih.gov/12362222